Reduced thrombin generation increases host susceptibility to group A streptococcal infection
Open Access
- 5 February 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (6), 1358-1364
- https://doi.org/10.1182/blood-2008-07-170506
Abstract
Bacterial plasminogen activators are commonplace among microbial pathogens, implying a central role of host plasmin in supporting bacterial virulence. Group A streptococci (GAS) secrete streptokinase, a specific activator of human plasminogen (PLG). The critical contribution of the streptokinase-PLG interaction to GAS pathogenicity was recently demonstrated using mice expressing human PLG. To examine the importance of thrombin generation in antimicrobial host defense, we challenged mice with deficiency of factor V (FV) in either the plasma or platelet compartment. Reduction of FV in either pool resulted in markedly increased mortality after GAS infection, with comparison to heterozygous F5-deficient mice suggesting a previously unappreciated role for the platelet FV pool in host defense. Mice with complete deficiency of fibrinogen also demonstrated markedly increased mortality to GAS infection relative to controls. Although FV Leiden may be protective in the setting of severe sepsis in humans, no significant survival advantage was observed in GAS-infected mice carrying the FV Leiden mutation. Taken together, our data support the hypothesis that local thrombosis/fibrin deposition limits the survival and dissemination of at least a subset of microbial pathogens and suggest that common variation in hemostatic factors among humans could affect host susceptibility to a variety of infectious diseases.This publication has 43 references indexed in Scilit:
- Inherited defects of coagulation factor V: the hemorrhagic sideJournal of Thrombosis and Haemostasis, 2006
- The emerging role of platelets in adaptive immunityCellular Immunology, 2005
- Prospects for a Group A Streptococcal Vaccine: Rationale, Feasibility, and Obstacles--Report of a National Institute of Allergy and Infectious Diseases WorkshopClinical Infectious Diseases, 2005
- Unique in Vivo Modifications of Coagulation Factor V Produce a Physically and Functionally Distinct Platelet-derived CofactorOnline Journal of Public Health Informatics, 2004
- The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasisBlood, 2003
- Genetic risk factors of venous thrombosisHuman Genetics, 2001
- EditorialMethods, 2000
- Disseminated Intravascular CoagulationThe New England Journal of Medicine, 1999
- Switching serine protease specificityNature Structural & Molecular Biology, 1998
- Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor VNature, 1996